Earnings NewsHealthcareAkari Therapeutics reports Q4 resultsMar. 31, 2020 8:04 AM ETAkari Therapeutics, Plc (AKTX) StockAKTXBy: SA News Team Akari Therapeutics (NASDAQ:AKTX): Q4 GAAP EPS of $0.00. Cash of $5.7M Press Release Recommended For YouMore Trending NewsSee More »About AKTX StockSymbolLast Price% Chg1D5D1M6M1Y5Y10YMarket CapPEYield (TTM)Rev Growth (YoY)Prev. CloseCompare to PeersRelated StocksSymbolLast Price% ChgAKTX--Akari Therapeutics, PlcTrending AnalysisTrending News